Related to Horizon and University of Washington Partner to Apply Gene Editing to IPSCs

• Cellectis Bioresearch Sets Up U.S. Subsidiary to Promote Targeted Genome Engineering Products
  
• Fate and BD Join Forces to Develop Induced Pluripotent Stem Cell Tools
  
• Cellectis and the Center for iPS Cells Research and Application Join Forces
  
• ATMI Buys Partner Artelis to Acquire Disposable Bioreactor Platform and Expertise
  
• CDC to Use Automation Partnership's CompacT SelecT Cell Culture System
  
• Life Technologies to Provide Biopredic's Hepatic Cell Line
  
• Selexis Provides Zyngenia with Cell-Line Services for Antibody Production
  
• Stem Cell Environment Created that Provides Chemical, Electrical, and Mechanical Cues
  
• Investigators Find New Method to Create Mesenchymal-Like Stem Cells
  
• CIRM Gains Access to Five of BioTime’s ESC Lines
  
• Scientists Turn Stem Cells into Functioning Intestinal Tissue
  
• Precision BioSciences Receives $3M in U.S. Gov't Grants for Meganuclease Platform
  
• Illumina Acquires Epicentre to Own Sequencing Library Preparation Technology
  
• BD Extends Reagent Supply Contract with Abaxis
  
• NuGEN Ovation® Prokaryotic RNA-Seq Technology Penetrates Academic Market
  
• BioTime Buys Assets from Cell Targeting to Boost Its Regenerative Medicine Focus
  
• Researchers Identify miRNAs Involved in Cellular Reprogramming
  
• Ion Torrent to Provide Assembly and Analysis Solutions from DNAStar
  
• Lonza and California Stem Cell Introduce MotorPlate Human ESC-Derived Motor Neuron Progenitors
  
• BioCat to Distribute SwitchGear Genomics’ LightSwitch Luciferase Assay System